Remus Pharmaceuticals Share Price
₹2,223.30 +46.4 (2.13%)
17 Jan, 2025 03:56
Start SIP in REMUS
Start SIPPerformance
- Low
- ₹2,185
- High
- ₹2,225
- 52 Week Low
- ₹1,200
- 52 Week High
- ₹2,835
- Open Price₹2,185
- Previous Close₹2,177
- Volume700
Investment Returns
- Over 1 Month -10.51%
- Over 3 Month -17.01%
- Over 6 Month + 11.84%
- Over 1 Year + 33.98%
Smart Investing Starts Here Start SIP with Remus Pharmaceuticals for Steady Growth!
Remus Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 50.4
- PEG Ratio
- -
- Market Cap Cr
- 1,310
- P/B Ratio
- 13
- Average True Range
- 126.05
- EPS
- 34.52
- Dividend Yield
- 0
- MACD Signal
- -54.31
- RSI
- 41.05
- MFI
- 44.19
Remus Pharmaceuticals Financials
Remus Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,223.30
+
46.4
(2.13%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹2,346.10
- 50 Day
- ₹2,422.93
- 100 Day
- ₹2,402.75
- 200 Day
- ₹2,213.36
Resistance and Support
2211.1
- R3 2,277.20
- R2 2,251.10
- R1 2,237.20
- S1 2,197.20
- S2 2,171.10
- S3 2,157.20
Remus Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Remus Pharmaceuticals F&O
About Remus Pharmaceuticals
- NSE Symbol
- REMUS
- BSE Symbol
- Managing Director
- Mr. Arpit Deepakkumar Shah
- ISIN
- INE0O5T01011
Similar Stocks to Remus Pharmaceuticals
Remus Pharmaceuticals FAQs
Remus Pharmaceuticals share price is ₹2,223 As on 17 January, 2025 | 03:42
The Market Cap of Remus Pharmaceuticals is ₹1310 Cr As on 17 January, 2025 | 03:42
The P/E ratio of Remus Pharmaceuticals is 50.4 As on 17 January, 2025 | 03:42
The PB ratio of Remus Pharmaceuticals is 13 As on 17 January, 2025 | 03:42
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.